郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

心血管疾病Parthenolide inhibits nociception and neurogenic vasodilatation in the trigeminovascular system by targeting the TRPA1 channel.

期刊：Pain发表年份：2013作者：Serena Materazzi; Silvia Benemei; Camilla Fusi; Roberta Gualdani; Gaetano De Siena; Nisha Vastani; David A Andersson; Gabriela Trevisan; Maria Rosa Moncelli; Xiaomei Wei; Gregory Dussor; Federica Pollastro; Riccardo Patacchini; Giovanni Appendino; Pi
阅读更多 →

心血管疾病An in vitro investigation of the cardiovascular effects of the 5-HT(4) receptor selective agonists, velusetrag and TD-8954.

期刊：Vascular pharmacology发表年份：2013作者：D T Beattie; D L Higgins; M P Ero; S M Amagasu; R G Vickery; K Kersey; A Hopkins; J A M Smith
阅读更多 →

心血管疾病Tetraspanin CD9 links junctional adhesion molecule-A to αvβ3 integrin to mediate basic fibroblast growth factor-specific angiogenic signaling.

期刊：Molecular biology of the cell发表年份：2013作者：Swetha S D Peddibhotla; Benjamin F Brinkmann; Daniel Kummer; Hüseyin Tuncay; Masanori Nakayama; Ralf H Adams; Volker Gerke; Klaus Ebnet
阅读更多 →

心血管疾病The nociceptin/orphanin FQ receptor antagonist UFP-101 reduces microvascular inflammation to lipopolysaccharide in vivo.

期刊：PloS one发表年份：2013作者：Zoë L S Brookes; Emily N Stedman; Nicola J Brown; Christopher P Hebbes; Remo Guerrini; Girolamo Calo; Charles S Reilly; David G Lambert
阅读更多 →